Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Common Equity: 2021-2023

Historic Common Equity for Zymeworks (ZYME) over the last 1 years, with Sep 2023 value amounting to $424.3 million.

  • Zymeworks' Common Equity rose 136.06% to $424.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $424.3 million, marking a year-over-year increase of 136.06%. This contributed to the annual value of $493.0 million for FY2022, which is 97.90% up from last year.
  • As of Q3 2023, Zymeworks' Common Equity stood at $424.3 million, which was down 5.47% from $448.9 million recorded in Q2 2023.
  • Over the past 5 years, Zymeworks' Common Equity peaked at $493.0 million during Q4 2022, and registered a low of $179.8 million during Q3 2022.
  • In the last 3 years, Zymeworks' Common Equity had a median value of $436.6 million in 2023 and averaged $378.1 million.
  • Data for Zymeworks' Common Equity shows a peak YoY spiked of 136.06% (in 2023) over the last 5 years.
  • Quarterly analysis of 3 years shows Zymeworks' Common Equity stood at $249.1 million in 2021, then spiked by 97.90% to $493.0 million in 2022, then surged by 136.06% to $424.3 million in 2023.
  • Its Common Equity was $424.3 million in Q3 2023, compared to $448.9 million in Q2 2023 and $473.5 million in Q1 2023.